5-Bromo-3-methoxypyridin-2-amine, 95.0%, 10g

Methyl 5-chloropyridine-2-carboxylate, 95.0%, 1g

1-[(3,5-dimethylisoxazol-4-yl)methyl]piperazine, 90.0%, 500mg

2-[(2,5-Dichlorophenyl)sulfonyl]propanehydrazide, 97.0%, 10g

(4-Chloro-3-(morpholine-4-carbonyl)phenyl)boronic acid, 95.0%, 250mg

Objectif IOS corrigé à l'infini, phase plan longue distance de travail, contraste Fluarex 20x/0,45, corrigé pour une épaisseur de boîte de Pétri de 1 mm

tert-Butyl 4-(2-bromoethyl)piperazine-1-carboxylate, 95.0%, 100mg

1-ethyl-2-methyl-1H-indole-3-carbonitrile, 95.0%, 1g

N-Methyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

Di-n-octyl ether, 96.0%, 25ml

4-Bromo-5-fluoro-2-nitrobenzoic acid, 95.0%, 10g

N-methyl-1-(4-methyl-1H-imidazol-2-yl)methanamine dihydrochloride, 95.0%, 5g

3-Bromo-5-fluoro-4-nitrobenzonitrile, 95.0%, 10g